In the present study, almost all HVPTC cases (16/17, 94.1%) harbored a BRAF V600E mutation, which indicated that BRAF mutation is quite often in HVPTC and might play an important role in its carcinogenesis and cancer progression. Here, BRAF is linked to cancer.